Alnylam Pharmaceuticals | 销售和管理费用

Selling And Administration Expenses 更改 日
Acadia Pharmaceuticals USD 107.99M 3.47M 2024-03
Agios Pharmaceuticals USD 31.01M 4.29M 2024-03
Alnylam Pharmaceuticals USD 210.8M 12.67M 2024-03
Amgen USD 1.81B 44M 2024-03
Arrowhead Research USD 24.64M 1.54M 2024-03
Avrobio USD 7.26M 2.02M 2024-03
BioMarin Pharmaceutical USD 225.91M 49.12M 2024-03
Incyte USD 300.3M 6.44M 2024-03
Ionis Pharmaceuticals USD 52.64M 18.37M 2024-03
Moderna USD 274M 196M 2024-03
Neurocrine Biosciences USD 243.1M 38.9M 2024-03
Novartis USD 2.84B 604M 2024-03
PTC Therapeutics USD 73.27M 3.02M 2024-03
Regeneron Pharmaceuticals USD 689M 48.7M 2024-03
Sanofi EUR 2.6B 26M 2024-03
Sarepta Therapeutics USD 127M 6.11M 2024-03
Takeda JPY 267.52B 14.57B 2023-12
Ultragenyx Pharmaceutical USD 78.16M 1.33M 2024-03
Vertex Pharmaceuticals USD 342.7M 78.9M 2024-03
Xencor USD 13.79M 1.69M 2024-03



Alnylam Pharmaceuticals 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.